Latest Articles

Publication Date
Arimoclomol-loaded Pluronic F127 nanomicelles in experimental endometriosis: drug incorporation, in vitro release, and early morphological and histological responses.

Endometriosis is a chronic, estrogen-dependent inflammatory disease characterized by ectopic endometrial-like glands and stroma, persistent pelvic inflammation, pain, infertility, and frequent recurrence. The limited availability of nonhormonal and lesion-directed therapies …

Published: Sept. 23, 2026, midnight
Canada’s first-ever endometrial cancer awareness week - CTV News

Canada’s first-ever endometrial cancer awareness week CTV News

Published: Sept. 22, 2026, 2:27 p.m.
Canada’s first-ever endometrial cancer awareness week - ctvnews.ca

Canada’s first-ever endometrial cancer awareness week ctvnews.ca

Published: Sept. 22, 2026, 2:27 p.m.
Endometrial Cancer Pipeline Insight 2026: 50+ Companies - openPR.com

Endometrial Cancer Pipeline Insight 2026: 50+ Companies openPR.com

Published: Sept. 21, 2026, 12:52 p.m.
Endometrial Cancer Pipeline Insight 2026: 50+ Companies - openpr.com

Endometrial Cancer Pipeline Insight 2026: 50+ Companies openpr.com

Published: Sept. 21, 2026, 12:52 p.m.
Depot medroxyprogesterone acetate and the risk for developing an intracranial meningioma.

Several investigations have reported on the increased risk of meningioma following depot medroxyprogesterone acetate (DMPA) treatment. An extensive PubMed search was conducted evaluate systematic reviews, propensity-matched studies and case-control studies …

Published: Sept. 21, 2026, midnight
Methodological Pitfalls in Endometriosis Biospecimen Research: Lessons From MAP4K4 Expression Studies.

Endometriosis is a chronic inflammatory condition affecting 10% of reproductive-age women. Current treatments remain limited and non-curative. While its biology is largely informed by human biospecimens, sample heterogeneity and methodological …

Published: Sept. 21, 2026, midnight
Cholesterol Enzyme DHCR24 Emerges as Driver and Biomarker of Endometrial Cancer - Bioengineer.org

Cholesterol Enzyme DHCR24 Emerges as Driver and Biomarker of Endometrial Cancer Bioengineer.org

Published: Sept. 20, 2026, 11:23 p.m.
Cholesterol Enzyme DHCR24 Emerges as Driver and Biomarker of Endometrial Cancer - bioengineer.org

Cholesterol Enzyme DHCR24 Emerges as Driver and Biomarker of Endometrial Cancer bioengineer.org

Published: Sept. 20, 2026, 11:23 p.m.
Two drugs approved separately eliminate 60% of endometrial tumors when combined in trials in Catalonia - APD Noticies

Two drugs approved separately eliminate 60% of endometrial tumors when combined in trials in Catalonia APD Noticies

Published: Sept. 19, 2026, 10:17 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!